-- FactSetが調査したアナリストによると、KKR（KKR）の平均投資判断は「買い」、平均目標株価は123.94ドルです。 （は、北米、アジア、ヨーロッパの主要銀行および調査会社による株式、商品、経済に関する調査レポートを配信しています。調査レポート提供者の方は、こちらからお問い合わせください：https://www..com/contact-us）
Price: $100.51, Change: $-0.28, Percent Change: -0.28%
Related Articles
Mining & Metals
WELL Health Technologies Q1 Adjusted Earnings, Revenue Beat Estimates
WELL Health Technologies (WELL.TO) Thursday after trade reported adjusted first-quarter earnings and revenue that both beat estimates.Adjusted net income, excluding most one-time items, more than doubled to $15.5 million, or $0.06 per share, from $7.5 million, or $0.03, in the prior year period. The result beat the consensus analyst estimate of $0.05 per share, according to FactSet.Revenues surged 25% to $368.3 million, beating the $366.98 million forecast. The increase was driven by organic growth, acquisitions and the inclusion of Healwell results in WELL's consolidated financial reporting, a statement said.Total patient visits rose 17% year-over-year to 1.9 million. At the end of the first quarter, WELL reported 253 clinics across Canada, including primary care, diagnostics, allied health, specialty and executive health clinics.WELL maintained its guidance for annual revenue of between $1.55 billion to $1.65 billion with adjusted EBITDA in the range of $175 million to $185 million."We are very pleased to report a strong start to 2026, with solid first quarter performance that saw our revenue run rate approach the $1.5 billion per year mark. Our Canadian clinics business continued to be a key driver of growth, achieving a revenue run rate of over half a billion dollars per year while delivering 30% year-over-year revenue growth, including 13% organic growth," said chief executive Hamed Shahbazi.Well Health shares closed up $0.03 to $4.37 on the Toronto Stock Exchange.
$WELL.TO
Australia
Trade Desk Q1 Adjusted Earnings Fall, Revenue Rises; Q2 Guidance Set
Trade Desk (TTD) reported Q1 adjusted earnings late Thursday of $0.28 per diluted share, down from $0.33 a year earlier.Analysts polled by FactSet expected $0.32.Revenue for the three months ended March 31 was $688.9 million, up from $616 million a year earlier.Analysts surveyed by FactSet expected $678.9 million.For Q2, the company expects revenue of at least $750 million. Analysts expect $771.2 million.
$TTD
Insider Trading
Datadog Insider Sold Shares Worth $2,078,550, According to a Recent SEC Filing
Kerry Acocella, General Counsel and Secretary, on May 05, 2026, sold 13,857 shares in Datadog (DDOG) for $2,078,550. Following the Form 4 filing with the SEC, Acocella has control over a total of 140,489 Class A common shares of the company, with 140,489 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1561550/000156155026000131/xslF345X05/wk-form4_1778185858.xml
$DDOG